Single-shot bevacizumab for cerebral radiation injury.
Martin VossKatharina Johanna WengerEmmanouil FokasMarie-Therese ForsterJoachim P SteinbachMichael W RonellenfitschPublished in: BMC neurology (2021)
Single-shot bevacizumab therefore has meaningful activity in cerebral radiation injury, but durable control is rarely achieved. In patients where a complete protocol of four infusions with bevacizumab is not feasible due to medical contraindications or lack of reimbursement, single-shot bevacizumab treatment may be considered.